DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.

Kerdivel G, Amrouche F, Calmejane MA, Carallis F, Hamroune J, Hantel C, Bertherat J, Assié G, Boeva V

Open source

DOI
10.1186/s13148-023-01534-5
Published
2023 Aug 2
Container
Clinical epigenetics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13148-023-01534-5,
  title = {DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.},
  author = {Kerdivel G and Amrouche F and Calmejane MA and Carallis F and Hamroune J and Hantel C and Bertherat J and Assié G and Boeva V},
  year = {2023},
  journal = {Clinical epigenetics},
  doi = {10.1186/s13148-023-01534-5},
  url = {https://doi.org/10.1186/s13148-023-01534-5}
}

RIS

TY  - JOUR
TI  - DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.
AU  - Kerdivel G
AU  - Amrouche F
AU  - Calmejane MA
AU  - Carallis F
AU  - Hamroune J
AU  - Hantel C
AU  - Bertherat J
AU  - Assié G
AU  - Boeva V
PY  - 2023
JO  - Clinical epigenetics
DO  - 10.1186/s13148-023-01534-5
UR  - https://doi.org/10.1186/s13148-023-01534-5
ER  - 

APA

G, K., F, A., MA, C., F, C., J, H., C, H., J, B., G, A., & V, B. (2023). DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.. Clinical epigenetics. https://doi.org/10.1186/s13148-023-01534-5

Source records